UroGen Pharma URGN Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$23.57M+46.2% | -$26.36M+29.7% | -$33.35M-40.9% | -$49.94M-49.5% | -$43.84M-35.8% | ||
| $75K+4.2% | $75K+10.3% | $100K0.0% | $100K0.0% | $72K-41.5% | ||
| $4.63M+50.8% | $3.13M-5.2% | $3.03M-13.2% | $2.73M-23.2% | $3.07M+11.4% | ||
| -$45.32M-7.8% | -$38.33M-181% | -$42.27M-52.8% | -$39.83M-67.7% | -$42.02M-32.4% | ||
| $54K+22.7% | $17K-85.2% | $87K-9.4% | $141K+67.9% | $44K— | ||
| -$20.69M+20.3% | $27.72M— | $31.4M+129% | $28.41M+137% | -$25.96M-292% | ||
| $65.35M— | $0-100% | —— | —— | $0-100% | ||
| $65.2M+191,676% | $31.32M+44,007% | $8.27M-79.1% | $296K-99.7% | $34K-99.9% | ||
| -$800K+98.8% | —— | -$2.6M— | -$11.12M-113% | -$67.95M-286% | ||
| -$45.37M-7.8% | -$38.34M-179% | -$42.36M-52.6% | -$39.97M-67.7% | -$42.07M-32.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does UroGen Pharma generate?
- UroGen Pharma (URGN) generated -$165.7M in operating cash flow over the trailing twelve months.
- What is UroGen Pharma's free cash flow?
- After $299.0K of capital expenditures, UroGen Pharma's free cash flow was -$166.0M over the trailing twelve months, down 54.6% year over year.
- Where does UroGen Pharma's cash flow data come from?
- Every line is extracted from UroGen Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
